Background and study aims: A second-generation capsule endoscopy system, using the PillCam Colon 2, was developed to increase sensitivity for colorectal polyp detection compared with the first-generation system. The performance of this new system is reported.
Patients and methods: In a five-center feasibility study, second-generation capsule endoscopy was prospectively compared with conventional colonoscopy as gold standard for the detection of colorectal polyps and other colonic disease, in a cohort of patients scheduled for colonoscopy and having known or suspected colonic disease. Colonoscopy was independently performed within 10 hours after capsule ingestion. Capsule-positive but colonoscopy-negative cases were counted as false-positive.
Results: 104 patients (mean age 49.8 years) were enrolled; data from 98 were analyzed. Patient rate for polyps of any size was 44 %, 53 % of these patients having adenomas. No adverse events related to either procedure were reported. The capsule sensitivity for the detection of patients with polyps ≥ 6 mm was 89 % (95 % confidence interval [CI] 70 – 97) and for those with polyps ≥ 10 mm it was 88 % (95 %CI 56 – 98), with specificities of 76 % (95 %CI 72 – 78) and 89 % (95 %CI 86 – 90), respectively. Both polyps missed by colonoscopy and mismatch in polyp size by study definition lowered specificity. Overall colon cleanliness for capsule endoscopy was adequate in 78 % of patients (95 %CI 68 – 86).
Conclusions: The new second-generation colon capsule endoscopy is a safe and effective method for visualizing the colon and detecting colonic lesions. Sensitivity and specificity for detecting colorectal polyps appear to be very good, suggesting a potential for improved accuracy compared with the first-generation system. Further prospective and comparative studies are needed.
References
1
Levin B, Lieberman D A, McFarland B. et al .
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the American College of Radiology.
Gastroenterology.
2008;
134
1570-1595
2
Ponchon T.
Colon tumors and colonoscopy.
Endoscopy.
2007;
39
992-997
3
Eliakim R, Fireman Z, Gralneck I M. et al .
Evaluation of the Pillcam colon capsule in the detection of colonic pathology: results of the first multicenter prospective, comparative study.
Endoscopy.
2006;
38
963-970
4
Schoofs N, Deviere J, Van Possum A.
Pillcam colon capsule endoscopy compared with colonoscopy for colorectal diagnosis: a prospective pilot study.
Endoscopy.
2006;
38
971-977
5
Van Gossum A, Navas M M, Fernandez-Urien I. et al .
Capsule endoscopy versus colonoscopy for the detection of polyps and cancer.
New England J Med.
2009;
361
264-270
6
Chiu H M, JT W ang, Lee Y C, Wu M S.
The impact of colon preparation timing on colonoscopic detection of colorectal neoplasms – a prospective endoscopist-blinded randomized trial.
Am J Gastroenterol.
2006;
101
2719-2725
7
Ben Horin S, Bar-Meir S, Avidan B.
The impact of colon cleanliness assessment on endoscopists’ recommendations for follow-up colonoscopy.
Am J Gastroenterol.
2007;
102
2680-2685
R. EliakimMD
Department of Gastroenterology Rambam Health Care Campus
Bat Galim, Haifa, 91630 Israel
Fax: 972-4-8543058
Email: r_eliakim@rambam.health.gov.il